Authors:
Terwogt, JMM
Huinink, WWT
Schellens, JHM
Schot, M
Mandjes, IAM
Zurlo, MG
Rocchetti, M
Rosing, H
Koopman, FJ
Beijnen, JH
Citation: Jmm. Terwogt et al., Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel, ANTI-CANC D, 12(4), 2001, pp. 315-323
Authors:
Terwogt, JMM
Rosing, H
Rocchetti, M
Frigerio, E
Fraier, D
Koopman, FJ
Schellens, JHM
Huinink, WWT
Beijnen, JH
Citation: Jmm. Terwogt et al., High-performance liquid chromatographic methods for the determination of anovel polymer-bound paclitaxel derivative and free paclitaxel in human plasma, J LIQ CHR R, 23(8), 2000, pp. 1233-1251
Authors:
Terwogt, JMM
van Tellingen, O
Panday, VRN
Huizing, MT
Schellens, JHM
Huinink, WWT
Boschma, MUS
Giaccone, G
Veenhof, CHN
Beijnen, JH
Citation: Jmm. Terwogt et al., Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients, ANTI-CANC D, 11(9), 2000, pp. 687-694
Authors:
Terwogt, JMM
Tibben, MM
Welbank, H
Schellens, JHM
Beijnen, JH
Citation: Jmm. Terwogt et al., Validated method for the determination of platinum from a liposomal source(SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry, FRESEN J AN, 366(3), 2000, pp. 298-302
Citation: Jmm. Terwogt et al., Clinical pharmacology of anticancer agents in relation to formulations andadministration routes, CANC TR REV, 25(2), 1999, pp. 83-101
Authors:
Terwogt, JMM
Mandjes, IAM
Sindermann, H
Beijnen, JH
Huinink, WWTB
Citation: Jmm. Terwogt et al., Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer, BR J CANC, 79(7-8), 1999, pp. 1158-1161